Is CBD Legal in California? California Cannabis, Hemp, and CBD Laws (2026)

California permits CBD products under different rules for industrial hemp, licensed cannabis, and approved medicines. The exact formulation and product category matter: the rules for a CBD beverage are not identical to those for a skin cream or a dispensary product.

Assembly Bill 8 introduced new requirements in January 2026, with further hemp integration scheduled for January 2028. Federal hemp changes also have separate November and December 2026 deadlines. A product being offered in a shop or online is not proof that it meets these requirements.

Which Agency Regulates a CBD Product?

The California Department of Public Health oversees manufactured industrial hemp products through its Industrial Hemp Enrollment and Oversight program. The Department of Cannabis Control oversees the licensed cannabis supply chain. FDA-approved cannabidiol medicine follows pharmaceutical requirements.

Hemp and marijuana are legal categories within cannabis. The federal hemp definition currently uses a delta-9 THC threshold of no more than 0.3% on a dry-weight basis, but meeting that threshold does not establish compliance with California’s finished-product rules or federal food law. Both source and formulation must be considered.

CBD Foods and Supplements Under AB 8

Assembly Bill 8, signed October 2, 2025, adds Health and Safety Code Section 111921.1. From January 1, 2026, industrial hemp raw extract used in food, food additives, beverages, or dietary supplements must consist of CBD or CBN isolate with purity greater than 99%, without THC or synthetic cannabinoids.

This concerns the ingredient’s purity, not a requirement that a finished drink or gummy be 99% CBD. Manufacturers must also comply with applicable CDPH authorization, testing, labeling, and other product requirements. Full-spectrum extract is not interchangeable with the specified isolate ingredient.

For industrial hemp foods, beverages, and dietary supplements intended for human consumption, California’s rules require no detectable THC or other intoxicating cannabinoids, a minimum purchase age of 21, and no more than five servings per package. These requirements apply alongside AB 8, rather than being replaced by its isolate requirement.

The CDPH rulemaking record reports approval of the regular serving-size and age regulations on October 20, 2025, and approval of the intoxicating-cannabinoid rulemaking on April 21, 2026. The latter should no longer be described as merely awaiting action after its December 2025 comment period.

Topical Cosmetics Have a Separate Rule

The CDPH AB 8 FAQ distinguishes cosmetic ingredients from the isolate requirements for foods and supplements. Starting January 1, 2026, industrial hemp extract used in cosmetics cannot contain THC, with an exception for extract used in topically applied cosmetics: it may contain up to 0.3% total THC on a dry-weight basis.

Consequently, it is inaccurate to say every CBD product outside a dispensary must be THC-free isolate. That does not mean any product called a cream qualifies. Its intended use, formulation, testing, and regulatory requirements still matter. A topical cosmetic is not the same category as an edible, and medical treatment claims raise additional drug-law issues.

Look for the exact product category and batch documentation. Do not infer compliance from “broad-spectrum,” “full-spectrum,” or “natural” branding alone.

Hemp Flower, Vapes, and Dispensary Integration

CDPH’s current guidance says that, from January 1, 2026, hemp flower, pre-rolls containing hemp flower or hemp-derived cannabinoids, and inhalable cannabis products containing hemp-derived THC cannot be sold, offered, or provided in California.

A prohibited hemp item cannot simply be moved to a dispensary shelf. Until January 1, 2028, Business and Professions Code Section 26000.5, added by AB 8, requires licensed manufacturers to use cannabinoid extracts and concentrates made exclusively from cannabis obtained from licensed cannabis cultivators. It also prohibits licensees from possessing, transporting, distributing, manufacturing, or selling industrial hemp on or from licensed premises, with an exception for licensed laboratory testing.

The state’s AB 8 implementation budget document describes rulemaking before hemp integration begins in January 2028. This is a phased transition, not a present authorization for every intoxicating hemp product to enter the licensed market.

Buying CBD Through the Cannabis System

CBD-containing cannabis products can be purchased through licensed cannabis retailers and licensed delivery services, subject to applicable rules. California permits adult-use purchases from age 21. Its medical-purchase guidance covers adults 18 and older with a current physician’s recommendation or qualifying medical identification, as well as primary caregivers.

Check the retailer through the Department of Cannabis Control. Read both CBD and THC quantities: a product promoted for its CBD content may still contain an intoxicating dose of THC. Cannabis testing and packaging requirements do not make every therapeutic claim on a product scientifically established.

Prescription cannabidiol is a separate route. Epidiolex is FDA approved for specified seizure disorders; its approval does not extend to other CBD brands or dispensary products.

California Permission Does Not Replace FDA Rules

California’s hemp-food framework does not amend federal law. The FDA prohibits marketing CBD as a dietary supplement and generally prohibits introducing foods with added CBD into interstate commerce. This is more than an absence of FDA approval.

A state-authorized manufacturer must consider those federal restrictions separately, particularly when shipping products across state lines. A disclaimer stating that the FDA has not evaluated a product does not legalize a prohibited product or an unapproved disease-treatment claim.

The Federal Hemp Timetable in Late 2026

Section 781 of Public Law 119-37 narrows the federal hemp definition. A September 2026 extension in Section 2019 defers most amendments to December 11, 2026. November 12 remains the start for exclusions covering intermediate and final products containing cannabinoids the cannabis plant cannot naturally produce.

The December provisions include a total-THC definition counting THCA, exclusions for naturally producible cannabinoids synthesized or manufactured outside the plant, and a finished-product exclusion above 0.4 mg per container of combined total THC and specified similarly acting cannabinoids. That is not a per-serving allowance or a limit on CBD itself.

These changes can affect full-spectrum formulations, including products that meet a state rule. California’s existing restrictions remain applicable during the extension. Neither a pending federal proposal nor California’s planned 2028 integration should be treated as permission to ignore the operative requirements.

Online Orders and Travel

Before ordering, verify the exact product’s compliance and the manufacturer’s applicable registration. A national supplier listing is not confirmation that every item the company offers may be shipped to California. Request a batch-specific laboratory report and check the product category rather than relying on a store’s location.

For travel, check the rules at departure, transit points, and the destination, along with the carrier’s requirements. The TSA cannabis page concerns airport screening; it does not provide a universal authorization under destination or customs law. A California cannabis purchase does not by itself authorize interstate or international transport.

The practical starting point is the product’s composition and regulatory category, followed by the seller’s credentials and current rules. Where an item happens to be displayed tells you much less than those checks.